LncRNA DGUOK-AS1 通过增强 EFTUD2 稳定性促进膀癌的进展
Wenwei Ying1, Dingliang Li2, Ninghan Feng3
1Department of Urology, Peking University First Hospital, Beijing, China.
Cancer research and treatment
|September 19, 2025
概括
长非编码RNA DGUOK-AS1通过增强细胞增殖和侵入来促进膀癌的进展. 这种lncRNA针对EFTUD2/MST1R/Akt通路,为膀癌提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 长非编码RNA (lncRNAs) 在癌症中起着关键作用,但它们的机制往往不清楚.
- 了解ncRNA功能对于癌症研究和治疗开发至关重要.
研究的目的:
- 在膀癌中识别差异表达的lncRNAs.
- 研究IncRNA DGUOK-AS1在膀癌进展中的功能作用和机制.
主要方法:
- RNA测序以比较非肌肉侵入性膀癌 (NMIBC) 和肌肉侵入性膀癌 (MIBC) 中的lncRNA.
- 在体外和体内测试以评估DGUOK-AS1功能.
- 分子测试 (RNA pull-down,RIP,co-IP,Western blot,RT-qPCR) 用于阐明DGUOK-AS1的调节机制.
主要成果:
- 与NMIBC相比,IncRNA DGUOK-AS1在MIBC中显著上调.
- DGUOK-AS1通过与EFTUD2.2相互作用,促进膀癌细胞的扩散和入侵.
- DGUOK-AS1通过防止其无处不在和降解来稳定EFTUD2,从而导致RON∆165异形的产生和Akt/PKB通路的激活.
结论:
- DGUOK-AS1通过EFTUD2/MST1R/Akt信号轴驱动膀癌的进展.
- DGUOK-AS1代表了膀癌治疗的有前途的治疗标.
相关概念视频
Non-LTR Retrotransposons
13.2K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.2K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
